Boston Scientific Corporation logo

Boston Scientific Corporation

BSX
HealthcareNYSEUnited States
68.42USD-1.13 (-1.62%)

About Boston Scientific

Boston Scientific Corporation develops, manufactures and markets medical devices for use across multiple interventional medical specialties worldwide.

It operates through three segments:

  • MedSurg:

    • Devices for diagnosing and treating gastrointestinal and pulmonary conditions

    • Urological and pelvic health products

  • Rhythm and Neuro:

    • Implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds)

    • Pacemakers and CRT pacemakers

    • Remote patient management systems

    • Electrophysiology solutions: 3D cardiac mapping, ablation and diagnostic catheters, ultrasound catheters, and delivery sheaths

    • Spinal cord stimulation systems (for chronic pain)

    • Indirect decompression and deep brain stimulation systems

  • Cardiovascular:

    • Interventional cardiology products: drug-eluting coronary stents, catheters for PCI, FFR devices, and intravascular ultrasound imaging

    • Structural heart therapies

    • Peripheral interventions: stents, balloons, wires, and atherectomy systems for arterial disease

    • Venous disease treatments: thrombectomy systems, thrombolysis systems, and stents

    • Oncology & embolization: peripheral embolization devices, radioactive microspheres, ablation and cryoablation systems, and drainage catheters

Founded in 1979, Boston Scientific is headquartered in Marlborough, Massachusetts.

Boston Scientific's Business Strategy

Boston Scientific has established itself as a leading medical device manufacturer by pursuing a focused diversification strategy across cardiovascular, rhythm management and MedSurg (medical surgical) specialties. The company targets high-growth, minimally invasive treatments that reduce patient trauma, hospital stays and recovery time compared to traditional…

Available on Finplify

Free account required

Sign up free

Our Take on Boston Scientific

Pros:

Minimally Invasive Medical Devices: Boston Scientific is a global leader in interventional devices, particularly in cardiology, urology, endoscopy, and neuromodulation. Its products are essential to treating chronic conditions with less invasive, cost-effective procedures, aligning with modern care trends.

Broad, Differentiated Product Line: Its…

Available on Finplify

Free account required

Sign up free

Company Details

Exchange
NYSE
Country
United States
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael F. Mahoney
Employees
53,000
IPO Date
1992-05-19
ISIN
US1011371077
Website
bostonscientific.com

Key Metrics

Market Cap
101.52BUSD
P/E Ratio (TTM)
35.68
Net Profit Margin
14.40%
Debt / Asset Ratio
0.28
Dividend Yield (TTM)
0.00%
Volume
1.19M
Avg Volume
12.23M
Shares Outstanding
1.48B
Free Float
99.62%
β Beta
0.66
52W Range
67.6 - 109.5

Fundamental Analysis

Proprietary 5-category scoring system

Score Fingerprint

Section Scores

Profitability
3.6/5Good
Liquidity
3.6/5Good
Leverage
4.0/5Good
Cash Flow
4.5/5Excellent
Valuation
3.0/5Average

Full Breakdown & Peer Ranking

See the detailed score for every metric and how this stock ranks against its sector peers

Unlock for free
Free to join

Unlock the full research on Boston Scientific

Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.

300+ Curated Stocks

A hand-picked universe of world-class businesses across every major market and sector.

AI Analyst Briefings

Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.

Proprietary Fundamentals

Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.